HIV or HIV-Therapy? Causal attributions of symptoms and their impact on treatment decisions among women and men with HIV

Table 4 Comparison of women (n = 77) and men (n = 85) on frequency of laboratory abnormalities: laboratory reports, self-reports, and patient awareness

	Laboratory reportSelf-report		Awareness†
Laboratory abnormality	Women (%)	Men (%)	Women (%)	Men (%)	Women (%)	Men (%)
Anemia
Grade 1	18	12	1	0	7	0
Renal parameter††
Grade 1	7**	25**	0	0	0	0
Liver parameter†††	55	68	21	16	38	23
Grade 1	42	54	13	10	31	18
Grade 2	9	11	5	4	56	36
Grade 3	4	4	3	2	75	50
Hyperglycemia	12	14	0	1	0	8
Grade 1	8	10	0	0	0	0
Grade 2	3	0	0	0	0	0
Grade 3	1	4	0	1	0	50
Elevated Lipids††††	55	66	11	15	20	23
Grade 1	47	54	8	10	17	18
Grade 2	8	10	3	5	38	50
Grade 3	-	2	-	1	-	50
Lactic Acidosis†††††
Grade 1	8	19	0	0	0	0

† Awareness refers to the percentage of laboratory abnormalities that were patient-reported
†† Abnormality in at least one renal parameter (creatinine, urea, uric acid, electrolytes)
††† Abnormality in at least one liver parameter (ALT, AST, ALP, GGT, bilirubine -except for benign hyperbilirubinemea under Atazanavir or Indinavir)
^†††† Abnormality in at least one lipid parameter (triglycerides, LDH, HDLH, total cholesterol)
^{†††††} Physician reports are only available on 13 women and 21 men.
Chi square test indicates significant difference between men and women at:
*p < .05 and**p < .01

ISSN: 2047-783X